Search bioRxiv⌕ Search

Biology subjects

Hassoun, S.

Publications and source records attributed to Hassoun, S..

12 recordsLinked to original sources

FLARE: Fine-grained Learning for Alignment of spectra-molecule REpresentation Enhances Metabolite Annotation

Accurate metabolite annotation via tandem mass spectrometry remains a major bottleneck in untargeted metabolomics. Recent implicit models that avoid molecular generation or spectra simulation have shown competitive performance by aligning spectra and molecular structures in the embedding space. Still, they overlook the detailed relationships between spectral peaks and molecular substructures that govern fragmentation. We introduce FLARE (Fine-grained Learning for Alignment of spectra-molecule REpresentations), a contrastive learning framework that leverages bidirectional peak-node alignment under learned weak supervision. Unlike models that rely solely on global embeddings, FLARE computes similarity via maxima over peak-to-atom and atom-to-peak interactions, capturing chemically meaningful local correspondences and enabling interpretable spectra-molecule matching. It achieves state-of-the-art results on MassSpecGym, with 43.15% rank@1 (mass-based) and 22.66% (formula-based), surpassing previous models by over 63%. FLAREs learned embeddings correspond with molecular classes, match fingerprint similarity, and detect differential metabolites in a breast cancer xenograft study, showcasing its translational potential.

systems biology↗

Fine-Grained Structural Classification of Biosynthetic Gene Cluster-Encoded Products

Biosynthetic gene clusters (BGCs) are responsible the biosynthesis of many natural products, including a multitude of effective therapeutics and their precursors. Advances in genomic data collection as well as computational techniques have made it possible to identify BGCs at scale. However, accurately determining the types of BGC-encoded products from genomic content remains elusive. Here, we introduce BGCat (BGC annotation tool), a machine learning method for fine-grained structural classification of BGC-encoded products, leveraging the NPClassifier natural product nomenclature. Our method leverages a pre-trained protein language model for creating meaningful gene representations and a deep neural network for class label prediction. We show the method outperforms state-of-the-art approaches in coarse-grained product classification and is effective for detailed classification. We implement a clustering-based augmentation strategy for BGC-product relationships, addressing a crucial gap in the available datasets. We then introduce the concept of product class profiles (PCPs) of gene cluster families (GCFs), associating each GCF with a probabilisitc distribution of product types and offering a new perspective on GCF functions. Lastly, we use BGCat to provide new product class labels for over 100k BGCs in antiSMASH DB that presently have minimal information about their products.

bioinformatics↗

Learning from All Views: A Multiview Contrastive Framework for Metabolite Annotation

Metabolomics, enabled by high-throughput mass spectrometry, promises to advance our understanding of cellular biochemistry and guide new discoveries in disease mechanisms, drug development, and personalized medicine. However, as the assignment of molecular structures to measured spectra is challenging, annotation rates remain low and hinder potential advancements. We present MultiView Projection (MVP), a novel framework for learning a joint embedding space between molecules and spectra by leveraging multiple data views: molecular graphs, molecular fingerprints, spectra, and consensus spectra. MVP builds on contrastive multiview learning to capture mutual information across views, leading to more robust and generalizable representations for spectral annotation. Unlike prior approaches that consider multiple views via concatenation or as targets of auxiliary tasks, MVP learns from all views jointly, resulting in improved molecular candidate ranking. Notably, MVP supports annotation using either individual spectra or consensus spectra, enabling flexible use of multiple measurements. On the MassSpecGym benchmark, we show that annotation using query consensus spectra significantly outperforms rank aggregation strategies based on constituent spectrum annotation. Using the consensus spectrum view, MVP achieves 35.99% and 13.96% rank@1 when retrieving candidates by mass and formula, respectively. When ranking using individual spectra, MVP demonstrates performance that is superior to or on par with existing methods, achieving 26.37% and 11.10% rank@1 for candidates by mass and formula, respectively. MVP offers a flexible, extensible foundation for learning from multiple molecule/spectra data views. For Table of Contents Only O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=105 SRC="FIGDIR/small/688047v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@f6c219org.highwire.dtl.DTLVardef@40f8d4org.highwire.dtl.DTLVardef@19031b6org.highwire.dtl.DTLVardef@1afa58d_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioinformatics↗

Computational Analysis of the Gut Microbiota-Mediated Drug Metabolism

The gut microbiota, an extensive ecosystem harboring trillions of bacteria, plays a pivotal role in human health and disease, influencing diverse conditions from obesity to cancer. Among the microbiotas myriad functions, the capacity to metabolize drugs remains relatively unexplored despite its potential implications for drug efficacy and toxicity. Experimental methods are resource-intensive, prompting the need for innovative computational approaches. We present a computational analysis, termed MDM, aimed at predicting gut microbiota-mediated drug metabolism. This computational analysis incorporates data from diverse sources, e.g., UHGG, MagMD, MASI, KEGG, and RetroRules. An existing tool, PROXIMAL2, is used iteratively over all drug candidates from experimental databases queried against biotransformation rules from RetroRules to predict potential drug metabolites along with the enzyme commission number responsible for that biotransformation. These potential metabolites are then categorized into gut MDM metabolites by cross referencing UHGG. The analysis efficacy is validated by its coverage on each of the experimental databases in the gut microbial context, being able to recall up to 74% of experimental data and producing a list of potential metabolites, of which an average of about 65% are relevant to the gut microbial context. Moreover, explorations into ranking metabolites, iterative applications to account for multi-step metabolic pathways, and potential applications in experimental studies showcase its versatility and potential impact beyond raw predictions. Overall, this study presents a promising computational framework for further research and applications gut MDM, drug development and human health.

systems biology↗

Evaluation of search-enabled Pre-trained Large Language Models on retrieval tasks for the PubChem Database

Databases are indispensable in biological and biomedical research, hosting vast amounts of structured and unstructured data, facilitating the organization, retrieval, and analysis of complex data. Database access, however, remains a manual, tedious, and sometimes overwhelming, task. We investigate in this study the current state of using pre-trained, search-enabled LLMs for data retrieval from biological databases. Equipped with internet search and code generation capabilities, LLMs promise to streamline database access through natural language, expedite search and knowledge retrieval, and provide coherent analytical summaries. As an example database, we focus on evaluating a current search-enabled LLMs (GPT-4o) for retrieval from the PubChem database, a flagship, heavily used database that plays a critical role in biological and biomedical research. As PubChem is an open archival repository, it provides a well-documented programmatic interface that can be exploited through LLM code generation capabilities. We evaluate retrieval tasks for eight common PubChem access protocols that were previously documented. The tasks include identifying interacting genes and proteins, finding drug-like compounds based on structural similarity, retrieving bioactivity data, and locating stereoisomers and isotopomers. We develop a methodology for adopting the protocols into an LLM-prompt, where we supplement the prompt with additional context through iterative prompt refinement as needed. To further evaluate the LLM capabilities, we instruct the LLM to perform the retrieval with and without using programmatic access. We compare the results (referred to as gold and silver answers) when using these retrieval modalities with two traditional retrieval baselines that include running the manual search steps for each reference protocol through the PubChem database web interface, and through the provided PUG (Power-User Gateway) programmatic access. We quantitatively and qualitatively summarize our results, showing that generating programmatic access is more likely to yield the correct answers. We highlight the value and limitations of using current search-based LLMs for database retrieval. We also provide guidance for the future development that can improve the accuracy and reliability of search-based LLMs.

bioinformatics↗

Protein-ligand co-design: a case for improving binding affinity between Type II NADH:quinone oxidoreductase and quinones

Biological engineering aims to enhance biological systems by designing proteins with improved catalytic properties or ligands with enhanced function. Typically, applications permit designing proteins, e.g., an enzyme in a biodegradation reaction, or ligands e.g., a drug for a target receptor, but not both. Yet, some applications can benefit from a more flexible approach where both the protein and ligand can be designed or modified together to enhance a desired property. To meet the need for this co-design capability, we introduce a novel co-design paradigm and demon- strate its application to Ndh2-quinone pairings to enhance their binding affinity. Ndh2, type-II NADH dehydrogenase, is an enzyme found in certain bacteria that facilities extracellular electron transfer (EET) when interacting with exogenous quinone mediators. This interaction leads to the generation of a detectable electric current that can be used for biosensing applications. Our results demonstrate the benefits of the co-design paradigm in realizing Ndh2-quinone pairings with enhanced binding affinities, therefore highlighting the importance of considering protein-ligand engineering from a holistic co-design perspective.

bioinformatics↗

Molecular structure discovery for untargeted metabolomics using biotransformation rules and global molecular networking

Although untargeted mass spectrometry-based metabolomics is crucial for understanding lifes molecular underpinnings, its effectiveness is hampered by low annotation rates of the generated tandem mass spectra. To address this issue, we introduce a novel data-driven approach, Biotransformation-based Annotation Method (BAM), that leverages molecular structural similarities inherent in biochemical reactions. BAM operates by applying biotransformation rules to known anchor molecules, which exhibit high spectral similarity to unknown spectra, thereby hypothesizing and ranking potential structures for the corresponding suspect molecule. BAMs effectiveness is demonstrated by its success in annotating suspect spectra in a global molecular network comprising hundreds of millions of spectra. BAM was able to assign correct molecular structures to 24.2 % of examined anchor-suspect cases, thereby demonstrating remarkable advancement in metabolite annotation.

bioinformatics↗

Extending PROXIMAL to predict degradation pathways of phenolic compounds in the human gut microbiota

Despite significant advances in reconstructing genome-scale metabolic networks, the understanding of cellular metabolism remains incomplete for many organisms. A promising approach for elucidating cellular metabolism is analysing the full scope of enzyme promiscuity, which exploits the capacity of enzymes to bind to non-annotated substrates and generate novel reactions. To guide time-consuming costly experimentation, different computational methods have been proposed for exploring enzyme promiscuity. One relevant algorithm is PROXIMAL, which strongly relies on KEGG to define generic reaction rules and link specific molecular substructures with associated chemical transformations. Here, we present a completely new pipeline, PROXIMAL2, which overcomes the dependency on KEGG data. In addition, PROXIMAL2 introduces two relevant improvements with respect to the former version: i) correct treatment of multi-step reactions and ii) tracking of electric charges in the transformations. We compare PROXIMAL and PROXIMAL2 in recovering annotated products from substrates in KEGG reactions, finding a highly significant improvement in the level of accuracy. We then applied PROXIMAL2 to predict degradation reactions of phenolic compounds in the human gut microbiota. The results were compared to RetroPath RL, a different and relevant enzyme promiscuity method. We found a significant overlap between these two methods but also complementary results, which open new research directions into this relevant question in nutrition.

biochemistry↗

Analysis of Metabolic Network Disruption in Engineered Microbial Hosts due to Enzyme Promiscuity

BackgroundIncreasing understanding of metabolic and regulatory networks underlying microbial physiology has enabled creation of progressively more complex synthetic biological systems for biochemical, biomedical, agricultural, and environmental applications. However, despite best efforts, confounding phenotypes still emerge from unforeseen interplay between biological parts, and the design of robust and modular biological systems remains elusive. Such interactions are difficult to predict when designing synthetic systems and may manifest during experimental testing as inefficiencies that need to be overcome. Despite advances in tools and methodologies for strain engineering, there remains a lack of tools that can systematically identify incompatibilities between the native metabolism of the host and its engineered modifications. ResultsTransforming organisms such as Escherichia coli into microbial factories is achieved via a number of engineering strategies, used individually or in combination, with the goal of maximizing the production of chosen target compounds. One technique relies on suppressing or overexpressing selected genes; another involves on introducing heterologous enzymes into a microbial host. These modifications steer mass flux towards the set of desired metabolites but may create unexpected interactions. In this work, we develop a computational method, termed Metabolic Disruption Workflow (MDFlow), for discovering interactions and network disruption arising from enzyme promiscuity - the ability of enzymes to act on a wide range of molecules that are structurally similar to their native substrates. We apply MDFlow to two experimentally verified cases where strains with essential genes knocked out are rescued by interactions resulting from overexpression of one or more other genes. We then apply MDFlow to predict and evaluate a number of putative promiscuous reactions that can interfere with two heterologous pathways designed for 3-hydroxypropic acid (3-HP) production. ConclusionsUsing MDFlow, we can identify putative enzyme promiscuity and the subsequent formation of unintended and undesirable byproducts that are not only disruptive to the host metabolism but also to the intended end-objective of high biosynthetic productivity and yield. In addition, we show how enzyme promiscuity can potentially be responsible for the adaptability of cells to the disruption of essential pathways in terms of biomass growth.

systems biology↗

Biological Filtering and Substrate Promiscuity Prediction for Annotating Untargeted Metabolomics

Mass spectrometry coupled with chromatography separation techniques provides a powerful platform for untargeted metabolomics. Determining the chemical identities of detected compounds however remains a major challenge. Here, we present a novel computational workflow, termed Expanded Metabolic Model Annotation (EMMA), that aims to strike a balance between discovering previously uncharacterized metabolites and the computational burden of annotation. EMMA engineers a candidate set, a listing of putative chemical identities to be used during annotation, through an expanded metabolic model (EMM). An EMM includes not only canonical substrates and products of enzymes already cataloged in a database through a reference metabolic model, but also metabolites that can form due to substrate promiscuity. EMMA was applied to untargeted LC-MS data collected from cultures of Chinese hamster ovary (CHO) cells and murine cecal microbiota. EMM metabolites matched, on average, to 23.92% of measured masses, providing a > 7-fold increase in the candidate set size when compared to a reference metabolic model. Many metabolites suggested by EMMA are not catalogued in PubChem. For the CHO cell, we experimentally confirmed the presence of 4-hydroxy-phenyllactate, a metabolite predicted by EMMA that has not been previously identified as part of CHO cell metabolism.

bioengineering↗

Towards creating an extended metabolic model (EMM) for E. coli using enzyme promiscuity prediction and metabolomics data

BackgroundMetabolic models are indispensable in guiding cellular engineering and in advancing our understanding of systems biology. As not all enzymatic activities are fully known and/or annotated, metabolic models remain incomplete, resulting in suboptimal computational analysis and leading to unexpected experimental results. We posit that one major source of unaccounted metabolism is promiscuous enzymatic activity. It is now well-accepted that most, if not all, enzymes are promiscuous - i.e., they transform substrates other than their primary substrate. However, there have been no systematic analyses of genome-scale metabolic models to predict putative reactions and/or metabolites that arise from enzyme promiscuity. ResultsOur workflow utilizes PROXIMAL - a tool that uses reactant-product transformation patterns from the KEGG database - to predict putative structural modifications due to promiscuous enzymes. Using iML1515 as a model system, we first utilized a computational workflow, referred to as Extended Metabolite Model Annotation (EMMA), to predict promiscuous reactions catalyzed, and metabolites produced, by natively encoded enzymes in E. coli. We predict hundreds of new metabolites that can be used to augment iML1515. We then validated our method by comparing predicted metabolites with the Escherichia coli Metabolome Database (ECMDB). ConclusionsWe utilized EMMA to augment the iML1515 metabolic model to more fully reflect cellular metabolic activity. This workflow uses enzyme promiscuity as basis to predict hundreds of reactions and metabolites that may exist in E. coli but have not been documented in iML1515 or other databases. Among these, we found that 17 metabolites have previously been documented in E. coli metabolomics studies. Further, 6 of these metabolites are not documented for any other E. coli metabolic model (e.g. KEGG, EcoCyc). The corresponding reactions should be added to iML1515 to create an Extended Metabolic Model (EMM). Other predicted metabolites and reactions can guide future experimental metabolomics studies. Further, our workflow can easily be applied to other organisms for which comprehensive genome-scale metabolic models are desirable.

systems biology↗

Establishing Synthesis Pathway-Host Compatibility viaEnzyme Solubility

Current pathway synthesis tools identify possible pathways that can be added to a host to produce a desired target molecule through the exploration of abstract metabolic and reaction network space. However, not many of these tools do explore gene-level information required to physically realize the identified synthesis pathways, and none explore enzyme-host compatibility. Developing tools that address this disconnect between abstract reactions/metabolic design space and physical genetic sequence design space will enable expedited experimental efforts that avoid exploring unprofitable synthesis pathways. This work describes a workflow, termed Probabilistic Pathway Assembly with Solubility Scores (ProPASS), which links synthesis pathway construction with the exploration of the physical design space as imposed by the availability of enzymes with characterized activities within the host. Predicted protein solubility propensity scores are used as a confidence level to quantify the compatibility of each pathway enzyme with the host (E. coli). This work also presents a database, termed Protein Solubility Database (ProSol DB), which provides solubility confidence scores in E. coli for 240,016 characterized enzymes obtained from UniProtKB/Swiss-Prot. The utility of ProPASS is demonstrated by generating genetic implementations of heterologous synthesis pathways in E. coli that target several commercially useful biomolecules.\n\nAvailabilityProSol DB data and code for ProPASS are available for download from https://github.com/HassounLab/

synthetic biology↗